ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 137 filers reported holding ABCELLERA BIOLOGICS INC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,266 | -28.8% | 710 | 0.0% | 0.00% | -33.3% |
| Q2 2023 | $4,587 | +71.3% | 710 | +100.0% | 0.00% | +200.0% |
| Q1 2023 | $2,677 | -25.6% | 355 | 0.0% | 0.00% | -50.0% |
| Q4 2022 | $3,596 | -70.0% | 355 | -71.7% | 0.00% | -71.4% |
| Q3 2022 | $12,000 | -99.9% | 1,255 | 0.0% | 0.01% | -12.5% |
| Q2 2022 | $13,366,000 | +15624.7% | 1,255 | -71.9% | 0.01% | -85.2% |
| Q4 2021 | $85,000 | +37.1% | 4,463 | +44.0% | 0.05% | +54.3% |
| Q3 2021 | $62,000 | +55.0% | 3,100 | +72.2% | 0.04% | +9.4% |
| Q2 2021 | $40,000 | – | 1,800 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $37,320,000 | 92.58% |
| Gruss & Co., LLC | 308,570 | $3,052,000 | 26.27% |
| Founders Fund Growth Management, LLC | 407,017 | $4,025,000 | 11.55% |
| Belmont Capital, LLC | 510,000 | $5,044,000 | 5.95% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $40,599,000 | 5.05% |
| GUARDIAN CAPITAL ADVISORS LP | 3,736,414 | $40,129,000 | 5.01% |
| Intellectus Partners, LLC | 1,091,505 | $10,795,000 | 3.84% |
| ArchPoint Investors | 617,213 | $6,104,000 | 2.49% |
| BRANDYWINE MANAGERS, LLC | 56,976 | $563,000 | 1.85% |
| Casdin Capital, LLC | 1,650,000 | $16,319,000 | 1.07% |